Imatinib mesylate

Imatinib mesylate
Trade Name Gleevec
Orphan Indication Idiopathic hypereosinophilic syndrome
USA Market Approval USA
USA Designation Date 2005-08-25 00:00:00
Sponsor Novartis Pharmaceuticals Corporation;One Health Plaza, Mail Code 105/1E870D;East Hanover, New Jersey, 07936